+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-03-04Number of Pages: 104

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast 2016 - 2024

 
Implantable drug delivery devices are drug eluting devices implanted at targeted sites for therapeutic applications. The global implantable drug delivery devices market was valued at USD 11.6 billion in 2011 and is expected to grow at a CAGR of 8.8% from 2012 to 2018 to reach an estimated value of USD 21.1 billion in 2018. The Asian implantable drug delivery devices market held a market share of over 15% in 2011 and will register the fastest CAGR during 2012 to 2018 owing to economic development in emerging economies such as India and China. 
 
In terms of market leaders for individual product segments, Medtronic led the market in the global implantable infusion pumps market in 2011; however, its market share is expected to plummet by 2018 due to the Class I product recall of SynchroMed II in 2012. On the other hand, Boston Scientific Corporation dominated the coronary drug eluting stents market in 2011. Furthermore, Allergan Inc. will dominate the global intraocular drug delivery market in the coming years, owing to the growing popularity of its biodegradable implant – “Ozurdex.” 
 
Implantable drug delivery devices gain precedence over other drug delivery devices due to the fact that these devices are implanted at the targeted site and deliver unaltered concentrations of drugs at regular intervals. The market overview and trends for the global implantable drug delivery devices is analyzed based on the following attributes:
 
  • Technological trends: The introduction of biodegradable technology based products such as biodegradable intraocular implants and bio-absorbable stents will accelerate the growth of the overall implantable drug delivery devices market. Moreover, these biodegradable implantable drug delivery devices will act as internal substitutes for already existing products such as non-biodegradable intraocular drug delivery implants and coronary drug eluting stents. 
  • External substitutes: The presence of external substitutes and their technological advancement will restrain the growth of the market. For instance, the market growth of the brachytherapy seeds market is impeded by the advent of new technologies and the improvement of pre-existing alternative technologies such as HDR devices, image guided brachytherapy (IGBT) and pulse dose rate (PDR) treatments. 
  • Barriers to new entrants: Implantable drug delivery devices are categorized as Class I high risk medical devices. The approval process of these medical devices involves complicated and stringent FDA and CE regulations and therefore, is an expensive and lengthy affair. Non-compliance of these regulations leads to product recalls. Moreover, the presence of manufacturers with large revenue base such as Merck, Bayer, and Johnson and Johnson, elevates the barrier to new entrants and makes it very difficult for new entrants to sustain themselves. 
  • Patent expiration: Patent expiration of implantable drug delivery devices plays a very important role in determining the competitive scenario and overall market growth. For instance, the patent for Bayer’s Mirena will expire in 2015 and this will open up the market for generic product manufacturers like Teva Pharmaceuticals.
  • Introduction of cheaper products especially in the global contraceptive drug delivery implants market will drive the market in the future. Manufacturers like Bayer and Merck have entered into strategic agreements with the UN, DFID and Marie Stopes International and are marketing their products in emerging and underdeveloped economies by reducing their prices by approximately 50%. Furthermore, the future market expansion strategies adopted by Shanghai Dahua Pharmaceuticals Co. Ltd., that markets its contraceptive drug delivery implant known as Sino-implant at approximately USD 8, will affect the market by stiffening the competition for players like Merck and Bayer.

 
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation: Implantable Drug Delivery Devices Market
 
Chapter 2 Executive Summary
 
Chapter 3 Market Overview
3.1 Market Dynamics
      3.1.1 Market Drivers
               3.1.1.1 Market Drivers For The Global Coronary Stents (Drug-Eluting And Bio-Absorbable Stents) Market
                          3.1.1.1.1 Increasing Prevalence Of Cardiovascular Diseases
                          3.1.1.1.2 Rising Number Of Interventional Cardiologists
                          3.1.1.1.3 Increasing Demand For Minimally Invasive Procedures
               3.1.1.2 Impact Analysis Of The Market Drivers For The Global Coronary Stents (Drug-Eluting And Bio-Absorbable Stents) Market
               3.1.1.3 Market Drivers For The Global Brachytherapy Seeds Market
                          3.1.1.3.1 Increasing Global Prevalence Of Prostate Cancer
                          3.1.1.3.2 Emergence Of New Disease Applications (Cervical Cancer, Breast Cancer)
               3.1.1.4 Impact Analysis Of Market Drivers For The Global Brachytherapy Seeds Market
               3.1.1.5 Market Drivers For The Global Implantable Drug Infusion Pumps Market
                          3.1.1.5.1 Rising Prevalence Of Global Colorectal Cancer
                          3.1.1.5.2 High Prevalence Of Chronic Pain-Causing Disorders
               3.1.1.6 Impact Analysis Of Market Drivers For The Global Implantable Drug Infusion Pumps Market
               3.1.1.7 Market Drivers For The Global Intraocular Drug Delivery Implants Market
                          3.1.1.7.1 Global Aging Population
                          3.1.1.7.2 Rising Patient Pool For Diabetes And Diabetic Retinopathy
               3.1.1.8 Impact Analysis Of Market Drivers For The Global Intraocular Drug Delivery Implants Market
               3.1.1.9 Market Drivers For The Global Contraceptive Drug Delivery Implants Market
                          3.1.1.9.1 Growing Prevalence Of Unwanted Pregnancies
                          3.1.1.9.2 Government And NGO Initiatives To Promote Contraceptive Products
               3.1.1.10 Impact Analysis Of Market Drivers For The Global Contraceptive Drug Delivery Implants Market
      3.1.2 Market Restraints
               3.1.2.1 Product Recalls, Lawsuits And The Introduction Of Internal Product Substitutes
               3.1.2.2 Stringent FDA And CE Approval Norms
               3.1.2.3 Implementation Of The Affordable Healthcare For America Act, 2010
               3.1.2.4 Impact Analysis Of The Market Restraints
      3.1.3 Opportunities
               3.1.3.1 Introduction Of New And Advanced Implantable Drug Delivery Devices
                          3.1.3.1.1 Microchips
                          3.1.3.1.2 Introduction Of Biodegradable Technology Based Products
3.2 Market Attractiveness Analysis For The Global Implantable Drug Delivery Devices Market
      3.2.1 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Product Types
      3.2.2 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Geography
3.3 Market Scenario And Market Trends
      3.3.1 Global Implantable Drug Devices Market, 2011 – 2018 (USD Million)

Chapter 4 Implantable Drug Delivery Devices Market, By Product Types
4.1 Overview
4.2 Global Implantable Coronary Drug Eluting Stents Market
      4.2.1 Global Implantable Coronary Drug Eluting Stents Market, 2010 – 2018 (USD Million)
4.3 Global Implantable Bio-Absorbable Stents Market
      4.3.1 Global Implantable Bio-Absorbable Stents Market, 2014 – 2018 (USD Million)
      4.3.2 Implantable Bio-Absorbable Stents - Manufacturers And Product Availability Status
4.4 Global Implantable Brachytherapy Seeds Market
      4.4.1 Global Implantable Brachytherapy Seeds Market, 2010 – 2018 (USD Million)
      4.4.2 Global Implantable Brachytherapy Seeds Market By Product Types, 2010 – 2018 (USD Million)
4.5 Global Implantable Drug Infusion Pumps Market
      4.5.1 Global Implantable Drug Infusion Pumps Market, 2010 – 2018 (USD Million)
4.6 Global Intraocular Drug Delivery Implants Market
      4.6.1 Global Intraocular Drug Delivery Implants Market, 2010 – 2018 (USD Million)
4.7 Global Contraceptive Drug Delivery Implants Market
      4.7.1 Intravaginal Rings
      4.7.2 Hormonal IUDs
      4.7.3 Subdermal Contraceptive Implants
      4.7.4 Global Contraceptive Drug Delivery Implants Market, 2010 – 2018 (USD Million)
      4.7.5 Global Contraceptive Implants Market By Product Types, 2010 – 2018 (USD Million)
 
Chapter 5 Global Implantable Drug Delivery Devices Market, By Technology
5.1 Overview
5.2 Global Biodegradable Drug Delivery Implant Technology Market
      5.2.1 Global Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)
5.3 Global Non – Biodegradable Drug Delivery Implant Technology Market
      5.3.1 Global Non – Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)
 
Chapter 6 Global Implantable Drug Delivery Devices Market, By Applications
6.1 Overview
6.2 Global Implantable Drug Delivery Devices For Ophthalmology Market
      6.2.1 Global Implantable Drug Delivery Devices In Ophthalmology Market, 2010 – 2018 (USD Million)
6.3 Global Implantable Drug Delivery Devices For Birth Control/Contraceptive Market
      6.3.1 Global Implantable Drug Delivery Devices For Birth Control/Contraceptive Market, 2010 – 2018 (USD Million)
6.4 Global Implantable Drug Delivery Devices For Cardiovascular Market
      6.4.1 Global Implantable Drug Delivery Devices For Cardiovascular Market, 2010 – 2018 (USD Million)
6.5 Global Implantable Drug Delivery Devices For Oncology Market
      6.5.1 Global Implantable Drug Delivery Devices For Oncology Market, 2010 – 2018 (USD Million)
6.6 Global Implantable Drug Delivery Devices For Others Market
      6.6.1 Global Implantable Drug Delivery Devices For Others Market, 2010 – 2018 (USD Million)
 
Chapter 7 Implantable Drug Delivery Devices Market By Geography
7.1 Overview
7.2 North America
      7.2.1 North America Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.2.2 Comparative Analysis Of The North American Implantable Drug Delivery Devices Market By Product Types, 2011 & 2018 (%)
      7.2.3 The North American Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
7.3 Europe
      7.3.1 Europe Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.3.2 Comparative Analysis Of The European Implantable Drug Delivery Devices Market By Product Types, 2011 & 2018 (%)
      7.3.3 Europe Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
7.4 Asia
      7.4.1 Asia Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.4.2 Comparative Analysis Of The Asian Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
      7.4.3 Asia Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
7.5 Rest Of The World (RoW)
      7.5.1 RoW Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.5.2 Comparative Analysis Of The RoW Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
      7.5.3 RoW Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 
(USD Million)
 
Chapter 8 Recommendations
8.1 Investing In Emerging Technologies And Identifying New Target Disease Segments To Invent New Products Catering To Nascent Segments, E.G. Microchips
8.2 Conducting Clinical Trials Via External Funding
8.3 Investing In Emerging Economies
8.4 Conducting Rigorous Research And Development Exercises
8.5 Investing In Advertising Campaigns
8.6 Tracking Patent Expiration Of Branded Products
 
Chapter 9 Competitive Landscape
9.1 Market Share Analysis, By Product Types, 2011
      9.1.1 Market Share Analysis For The Global Coronary Drug Eluting Stents Market, By Key Players, 2011
      9.1.2 Market Share Analysis For The Global Brachytherapy Seeds Market, By Key Players, 2011
      9.1.3 Market Share Analysis For The Global Intraocular Drug Delivery Implants Market, 2011
      9.1.4 Market Share Analysis For The Global Contraceptive Drug Delivery Implants Market, 2011
 
Chapter 10 Company Profiles
10.1 Merck
      10.1.1 Company Overview
      10.1.2 Financial Overview
      10.1.3 Business Strategies
                10.1.3.1 Corporate Social Responsibility
                10.1.3.2 R&D Initiatives
                10.1.3.3 Advertising And Internet Marketing
      10.1.4 Product Portfolio
      10.1.5 Recent Developments
10.2 Bausch & Lomb Inc.
      10.2.1 Company Overview
      10.2.2 Financial Overview
      10.2.3 Business Strategies
                10.2.3.1 Mergers, Acquisitions, And Takeovers
      10.2.4 Product Portfolio
      10.2.5 Recent Developments
10.3 Medtronic Inc.
      10.3.1 Company Overview
      10.3.2 Financial Overview
      10.3.3 Business Strategies
                          10.3.3.1.1 Investments In R&D
                          10.3.3.1.2 Investing In Emerging Economies
                          10.3.3.1.3 Patent Filing
                          10.3.3.1.4 Mergers And Acquisitions
      10.3.4 Product Portfolio
      10.3.5 Recent Developments
10.4 Allergan, Inc.
      10.4.1 Company Overview
      10.4.2 Financial Overview
      10.4.3 Business Strategies
                10.4.3.1 Investing In  Research And Development
                10.4.3.2 Providing Innovative Products
      10.4.4 Product Portfolio
      10.4.5 Recent Developments
10.5 Psivida Corp.
      10.5.1 Company Overview
      10.5.2 Financial Overview
      10.5.3 Business Strategies
                10.5.3.1 Filing Patents
                10.5.3.2 Strategic Alliance Development
      10.5.4 Product Portfolio
      10.5.5 Recent Developments
10.6 Bayer Healthcare
      10.6.1 Company Overview
      10.6.2 Financial Overview
      10.6.3 Business Strategies
                          10.6.3.1 R&D Initiatives
                          10.6.3.2 Investment In Growing Economies
                          10.6.3.3 Advertising Campaigns
      10.6.4 Product Portfolio
      10.6.5 Recent Developments
10.7 Nucletron
      10.7.1 Company Overview
      10.7.2 Financial Overview
      10.7.3 Business Strategies
                10.7.3.1 Training And Development
      10.7.4 Product Portfolio
      10.7.5 Recent Developments
10.8 Boston Scientific Corporation
      10.8.1 Company Overview
      10.8.2 Financial Overview
      10.8.3 Business Strategies
                10.8.3.1 Market Expansion By Entering Into Emerging Economies Like India, China And Brazil
                10.8.3.2 Cost Controlling And Quality Enhancement Through R&D Restructuring
                10.8.3.3 Mergers And Acquisitions
                10.8.3.4 Innovation
      10.8.4 Product Portfolio
      10.8.5 Recent Developments
10.9 Abbott Laboratories
      10.9.1 Company Overview
      10.9.2 Financial Overview
      10.9.3 Business Strategies
                10.9.3.1 Business Diversification
                10.9.3.2 R&D Initiatives
                10.9.3.3 Investing In Emerging Markets
      10.9.4 Product Portfolio
      10.9.5 Recent Developments

LIST OF FIGURES
 
Fig. 1 Market Segmentation: Implantable Drug Delivery Devices Market
Fig. 2 Global Implantable Drug Delivery Devices Market By Product Types, 2018 (USD Million)
Fig. 3 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Product Types
Fig. 4 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Geography
Fig. 5 Global Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 6 Comparative Analysis Of The Global Implantable Drug Delivery Devices Market By Product Types, 2011 & 2018 (%)
Fig. 7 Global Implantable Coronary Drug Eluting Stents Market, 2010 – 2018 (USD Million)
Fig. 8 Global Implantable Bio-Absorbable Stents Market, 2014 – 2018 (USD Million)
Fig. 9 Global Implantable Brachytherapy Seeds Market, 2010 – 2018 (USD Million)
Fig. 10 Global Implantable Drug Infusion Pumps Market, 2010 – 2018 (USD Million)
Fig. 11 Global Intraocular Drug Delivery Implants Market, 2010 – 2018 (USD Million)
Fig. 12 Global Contraceptive Drug Delivery Implants Market, 2010 – 2018 (USD Million)
Fig. 13 Comparative Analysis Of The Global Implantable Drug Delivery Devices Market By Technology Types, 2011 & 2018 (%)
Fig. 14 Global Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)
Fig. 15 Global Non – Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)
Fig. 16 Comparative Analysis Of Global Implantable Drug Delivery Devices By Application, 2011 & 2018 (%)
Fig. 17 Global Implantable Drug Delivery Devices In Ophthalmology Market, 2010 – 2018 (USD Million)
Fig. 18 Global Implantable Drug Delivery Devices For Birth Control/Contraceptive Market, 2010 – 2018 (USD Million)
Fig. 19 Global Implantable Drug Delivery Devices For Cardiovascular Market, 2010 – 2018 (USD Million)
Fig. 20 Global Implantable Drug Delivery Devices For Oncology Market, 2010 – 2018 (USD Million)
Fig. 21 Global Implantable Drug Delivery Devices For Others Market, 2010 – 2018 (USD Million)
Fig. 22 Comparative Analysis Of The Global Implantable Drug Delivery Devices By Geography, 2011 & 2018 (%)
Fig. 23 North America Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 24 Comparative Analysis Of The North American Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 25 Europe Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 26 Comparative Analysis Of European Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 27 Asia Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 28 Comparative Analysis Of The Asian Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 29 RoW Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 30 Comparative Analysis Of The RoW Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 31 Market Share Analysis For The Global Coronary Drug Eluting Stents Market, By Key Players, 2011
Fig. 32 Market Share Analysis For The Global Brachytherapy Seeds Market, By Key Players, 2011
Fig. 33 Merck: Annual Revenues, 2009 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)
Fig. 34 Medtronic Inc.: Net Sales, 2009 – 2011 (USD Million)
Fig. 35 Allergan Inc.: Annual Revenues, 2009 – 2011 (USD Million)
Fig. 36 Psivida: Annual Revenues, 2009-2011 (USD Million)
Fig. 37 Bayer Healthcare: Annual Revenues, 2009-2011 (USD Million) (Conversion Rate:  1 Euro = 1.34 USD)
Fig. 38 Elekta: Annual Revenues, 2010 - 2011 (USD Million) (Conversion Rate: 1 Sek = 0.16 USD)
Fig. 39 Boston Scientific Corporation: Annual Revenues, 2009-2011 (USD Million)
Fig. 40 Abbott Laboratories: Annual Revenues, 2009-2011 (USD Million)

LIST OF TABLES
 
Table 1 Market Snapshot: Global Implantable Drug Delivery Devices
Table 2 Impact Analysis Of Market Drivers For The Global Coronary Stents (Drug-Eluting And Bio-Absorbable Stents) Market
Table 3 Impact Analysis Of Market Drivers For The Global Brachytherapy Seeds Market
Table 4 Impact Analysis Of Market Drivers For The Global Implantable Drug Infusion Pumps Market
Table 5 Impact Analysis Of Market Drivers For The Global Intraocular Drug Delivery Implants Market
Table 6 Impact Analysis Of Market Drivers For The Global Contraceptive Drug Delivery Implants Market
Table 7 Impact Analysis Of Market Restraints For The Implantable Drug Delivery Devices Market
Table 8 Key Implantable Drug Eluting Stent Products By Manufacturers
Table 9 Implantable Bio-Absorbable Stents By Manufacturers And Product Availability Status
Table 10 Global Implantable Brachytherapy Seeds Market By Product Types, 2010 – 2018 (USD Million)
Table 11 Global Contraceptive Implants Market By Product Types, 2010 – 2018 (USD Million)
Table 12 The North American Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
Table 13 Europe Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
Table 14 Asia Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
Table 15 RoW Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)

Implantable Drug Delivery Devices Market: Overview  

The global implantable drug delivery devices market is one of the fastest growing markets in the global medical devices industry. Implantable drug delivery devices have already achieved a reasonable edge over many other drug delivery devices. The demand for implantable drug delivery devices such as implantable infusion pumps, contraceptive implants, bio-absorbable stents, intraocular drug delivery implants, and brachytherapy seeds is expected to increase in many emerging nations. The demand for non-biodegradable and biodegradable drug delivery devices is expected to increase, which is another factor predicted to propel the global market.

The report on the global implantable drug delivery devices market uses industry-standard tools such as SWOT analysis and Porter’s five force analysis to measure the important factors driving and restricting the market. Key companies operating in the global market are also listed in the report by the analysts. Key developments in the market and the innovative implantable drug delivery devices introduced by key companies are listed in the report. For a detailed competitive analysis, the global market is divided into segments and sub-segments. Analysts have also focused on the factors that could create new opportunities in the market for the startups.

Implantable Drug Delivery Devices Market: Trends and Opportunities

The global implantable drug delivery devices market is predicted to reach US$21.1 bn by 2018, expected to exhibit an 8.80% CAGR from 2012 to 2018. The occurrence of cardiovascular diseases is rising, which has led to the rising demand for implantable drug delivery devices. The increasing number of interventional cardiologist will also boost the demand for implantable drug delivery devices. The demand for minimally invasive procedures is expected to increase, which will further propel the global market.

However, the rising number of product recalls, the introduction of internet product substitutes and the increasing lawsuits will restrict the growth of the global implantable drug delivery devices market. Stringent government rules and approval norms from FDA are likely to plan an important role in the global market. The implementation of the Affordable healthcare for America Act, 2010 is another factor anticipated to restrict the global market. Although the market is expected to be affected by a few factors, the introduction of new implantable drug delivery devices will benefit the key companies to maintain their dominance. 

Implantable Drug Delivery Devices Market: Region-wise Outlook

Based on region, the global implantable drug delivery devices market is divided into Asia Pacific, North America, Europe, and Rest of the World. In 2011, the global market for implantable drug delivery devices was dominated by North America. The application of implantable drug delivery devices in cardiovascular disorders, ophthalmology, birth control, and oncology is rising in North America. This is predicted to help the North America market to maintain its dominance in the global market in the years to come. 

However, going forward, the Asia Pacific market is predicted to be the most promising markets for implantable drug delivery devices owing to the significant growth of emerging nations such as India and China.

Key Players mentioned in the Report:

Some of the leading companies operating in the global implantable drug delivery devices market are Allergan Inc, Medtronic Inc., Merck, Boston Scientific Corporation, Bausch and Lomb Inc., Bayer HealthCare, Nucletron, pSivida Corp., and Abbott Laboratories. With many new implantable drug delivery devices being in the pipeline, the key companies are aiming to maintain their dominance in the global market.

Major regions analyzed under this research report are:

  • Europe
  • North America
  • Asia Pacific
  • Rest of the World

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top